ArticleFrontiers in oncology2022

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer.

Emaan Haque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.